These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 18479513

  • 1. Isolation and characterization of cidofovir resistant vaccinia viruses.
    Becker MN, Obraztsova M, Kern ER, Quenelle DC, Keith KA, Prichard MN, Luo M, Moyer RW.
    Virol J; 2008 May 14; 5():58. PubMed ID: 18479513
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
    Smee DF, Sidwell RW, Kefauver D, Bray M, Huggins JW.
    Antimicrob Agents Chemother; 2002 May 14; 46(5):1329-35. PubMed ID: 11959564
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir.
    Kinchington PR, Araullo-Cruz T, Vergnes JP, Yates K, Gordon YJ.
    Antiviral Res; 2002 Oct 14; 56(1):73-84. PubMed ID: 12323401
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The 3'-to-5' exonuclease activity of vaccinia virus DNA polymerase is essential and plays a role in promoting virus genetic recombination.
    Gammon DB, Evans DH.
    J Virol; 2009 May 14; 83(9):4236-50. PubMed ID: 19224992
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus.
    James SH, Price NB, Hartline CB, Lanier ER, Prichard MN.
    Antimicrob Agents Chemother; 2013 Jul 14; 57(7):3321-5. PubMed ID: 23650158
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate.
    Magee WC, Hostetler KY, Evans DH.
    Antimicrob Agents Chemother; 2005 Aug 14; 49(8):3153-62. PubMed ID: 16048917
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibitory activity of alkoxyalkyl and alkyl esters of cidofovir and cyclic cidofovir against orthopoxvirus replication in vitro.
    Keith KA, Wan WB, Ciesla SL, Beadle JR, Hostetler KY, Kern ER.
    Antimicrob Agents Chemother; 2004 May 14; 48(5):1869-71. PubMed ID: 15105146
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir.
    Kern ER, Hartline C, Harden E, Keith K, Rodriguez N, Beadle JR, Hostetler KY.
    Antimicrob Agents Chemother; 2002 Apr 14; 46(4):991-5. PubMed ID: 11897580
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of vaccinia virus replication by two small interfering RNAs targeting B1R and G7L genes and their synergistic combination with cidofovir.
    Vigne S, Duraffour S, Andrei G, Snoeck R, Garin D, Crance JM.
    Antimicrob Agents Chemother; 2009 Jun 14; 53(6):2579-88. PubMed ID: 19307376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.